Skip to main content
Correction to: An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to <?6 years with chronic kidney disease receiving dialysis.
Predictors of patency for arteriovenous fistulae and grafts in pediatric hemodialysis patients.
An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to <?6 years with chronic kidney disease receiving dialysis.
Vitamin D insufficiency, hemoglobin, and anemia in children with chronic kidney disease.
Waist-to-height ratio, body mass index, and cardiovascular risk profile in children with chronic kidney disease.
COQ2 nephropathy: a treatable cause of nephrotic syndrome in children.
Effect of BMI on allograft function and survival in pediatric renal transplant recipients.
Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKiD) cohort.
Genetic abnormalities and prognosis in patients with congenital and infantile nephrotic syndrome.
Malcolm A. Holliday, M.D, January 12, 1924 - March 26, 2014.